Company news
EMV Capital PLC news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
ProAxsis is awarded a European CE Mark
September 4, 2017
ProAxsis awarded a Significant Innovate UK Grant
July 24, 2017
PDS Announces Clinical Collaboration with Merck
July 10, 2017
Glycotest Strengthens Intellectual Property Reach
July 7, 2017
Glycotest Update
June 26, 2017
Holdings in Company
June 16, 2017
Results of Placing and Subscription
May 26, 2017
Vortex Initiates Clinical Research Studies
May 24, 2017
ProAxsis announces additional IP
May 10, 2017
ProAxsis Presents New Data at Major US Conference
May 5, 2017
BTG purchases Wanda's shares in Oncoverse
April 24, 2017
Full Year Results for the year ended 31 Dec 2016
April 3, 2017
Vortex Biosciences Announces Publications
March 31, 2017
Notice of Preliminary Results
March 27, 2017
Vortex Biosciences Launches VTX-1 Liquid Biopsy
February 22, 2017
Vortex Biosciences' CSO Wins SLAS Innovation Award
February 15, 2017
Vortex Biosciences' CSO Finalist for SLAS Award
February 9, 2017
New CEO appointed to Wanda
December 20, 2016
Executed Warrants
December 16, 2016
Netscientific: Vortex Biosciences Analysis Data
November 18, 2016
Vortex Gains CE Mark and FDA Class 1 Registration
November 3, 2016
Vortex Biosciences Appoints Non-Executive Director
October 26, 2016
ProAxsis Gains CE Mark for its Respiratory Test
September 30, 2016
NetScientific Interim Results
September 27, 2016
Wanda Technology Selected by 24Hr HomeCare
September 23, 2016
Glycotest strengthens IP portfolio
September 12, 2016
Wanda Appoints Digital Health Non-Exec Director
September 8, 2016
Wanda Launches First Consumer App
August 19, 2016
Vortex Biosciences Appoints Experts to New SAB
August 18, 2016
Vortex Licenses Patents From Harvard University
August 3, 2016
Wanda Appoints Medical Director
July 27, 2016
A to Z Home Health Care selects Wanda technologies
July 22, 2016
Vortex Biosciences appoints Chairman of SAB
June 14, 2016
Confirmed Start Date for Ian Postlethwaite as CFO
June 10, 2016
Portfolio PDS Biotechnology presents at BIO 2016
June 7, 2016
NetScientific's Vortex presents data at AACR
April 18, 2016
PDS Biotechnology Reports Positive Phase 1 Results
April 13, 2016
Annual Financial Report
April 7, 2016
Netscientific Appoints Ian Postlethwaite as CFO
April 5, 2016
ProAxsis Forms Scientific Advisory Board
March 30, 2016
Notice of Results
March 24, 2016
Wanda Forms Scientific Advisory Board
March 16, 2016
Adoption of reduced disclosure framework
March 7, 2016
Vortex co-founder receives US Presidential award
March 1, 2016
Wanda and Dignity Health launch OncoVerse platform
February 29, 2016
NetScientific appoints Prof. Stephen Smith as NED
February 17, 2016
PDS Biotechnology partners with NCI
February 9, 2016
PDS Biotechnology adds drug development executives
January 20, 2016
Glycotest Inc. appoints medical advisory board
January 6, 2016
WANDA signs contract with HRS
January 4, 2016
Calls
The 5 newest of 14 calls. Every call is listed under its year.
- Emv Capital (LSE:EMVC) — Virtual Meet the Portfolio - AMR Bio and ProAxsis
Jul 27, 2026
Transcript - Emv Capital (LSE:EMVC) — Final Results for the year to 31 December 2025
May 19, 2026
Transcript - Emv Capital (LSE:EMVC) — Virtual Meet the Portfolio - Vortex and DName-iT
Feb 26, 2026
Transcript - Emv Capital (LSE:EMVC) — Virtual Meet the Portfolio – Wanda and DeepTech Recycling
Dec 1, 2025
Transcript - Emv Capital (LSE:EMVC) — Interim Results for the six months ended 30 June 2025
Sep 30, 2025
Transcript
Decks
The 5 newest of 15 decks. Every deck is listed under its year.
- H1 2026 Earnings Presentation
Earnings · 27 slides · Sep 24, 2026
- FY2025 Earnings Presentation
Earnings · 26 slides · May 19, 2026
- Investor Presentation (February 2026)
Investor deck · 29 slides · Feb 26, 2026
- Investor Presentation (December 2025)
Investor deck · 27 slides · Dec 1, 2025
- H1 2025 Earnings Presentation
Earnings · 31 slides · Sep 30, 2025